India - Express Pharma

19th International Conference of Drug Regulatory Authorities commences in India

Govt bans 156 FDCs with immediate effect

DCGI waives off local trials for drugs approved in well-regulated markets

Navigating the IPR maze: India’s pharmaceutical challenge

Revolutionising cancer treatment: The promise of point-of-care CAR-T therapy

Decoding Budget 2024-25: A lacklustre budget for pharma

Transforming India’s pharma sector: Opportunities and Innovations under Modi 3.0

Ayurveda market anticipated to hit $25 bn with international exports, says Dr Manoj Nesari

Greening India’s industrial horizon: Navigating climate resilience in pharma and beyond

Indian pharma industry in 21st century – What has changed for domestic supply?